Recent analyst reports show shifts in ratings for Bicycle Therapeutics, Pilgrim's Pride, NantHealth, and Provident Financial. Plus, a look at quantum computing stocks. Read more...

A quick look at today's business news, including a surge in climate tech investments, revised stock price targets for Canadian companies, and special passes for investors. Read more...

A summary of recent earnings projections, analyst ratings, and stock comparisons for several companies listed on the NASDAQ, including Brilliant Earth Group, KVH Industries, and more. Read more...

Nvidia and Palantir face contrasting fortunes as Nvidia weathers a stock dip despite strong growth, and Palantir sees analyst optimism despite a recent price pullback. Billionaire Stanley Druckenmiller shifts his AI investments. Read more...

Recent analyst actions have stirred the tech stock market, with upgrades and downgrades impacting companies like Viridian Therapeutics, Denali, GigaCloud, Intellia, Micron, and VEON. Read more...

This week's analyst activity includes price target adjustments for Portland General Electric, Neumora Therapeutics, Microchip Technology, ICON Public, and MongoDB. Read more...

Analyst ratings shift for major companies like Disney and HP, while HPE reports impressive revenue growth despite cash flow concerns. Plus, updates on Installed Building Products, MeridianLink, and Sunrun. Read more...

A roundup of recent analyst ratings and price target adjustments for companies like NetApp, Lexicon Pharmaceuticals, Medpace Holdings, and more. Plus, a look at Nvidia vs. Broadcom in the AI space. Read more...

Recent analyst downgrades have impacted the stock prices of several companies listed on the NYSE, including AES, Dell Technologies, GE Vernova, and Cava Group. This article provides an overview of these changes and their potential implications. Read more...

Several stocks have seen recent target price adjustments by analysts. This article summarizes the latest ratings and price target changes for Owens Corning, AES, ON, Fulgent Genetics, and Rexford Industrial Realty. Read more...

Scotiabank's recent analyst actions have significantly impacted several companies, with upgrades and downgrades affecting stock prices for firms like AT&T, Janux Therapeutics, and others. Read more...

Recent analyst reports show positive momentum for YETI, ON Semiconductor, and Eli Lilly, with raised price targets and continued "overweight" ratings. Plus, a look at Caterpillar as a potential dividend stock. Read more...

Okta (OKTA) receives multiple analyst upgrades and price target increases from firms like KeyCorp, DA Davidson, Mizuho, and Goldman Sachs, signaling strong market confidence. Read more...

Cantor Fitzgerald has issued "strong-buy" ratings for multiple stocks, including Immunovant, Ardelyx, Kura Oncology, and Mesoblast. Meanwhile, Bank of America adjusts price targets for Gilead Sciences and Immunovant. Read more...